Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Merck and Co., Inc. and Schering-Plough Corporation announced that they each have received a request for additional information from the U.S. Federal Trade Commission with respect to their previously announced proposed merger. The request for information from the FTC, often referred to as a "second request," was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.


Today in Regulatory Issues...keeping you current

Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address